Skip to content. | Skip to navigation

National Cancer Institute U.S. National Institutes of Health www.cancer.gov
Sections
Personal tools
Log in
 
You are here: Home › Biomarkers › EPM2A

EPM2A

Basics

Aliases:
This biomarker is also known as:
  • epilepsy, progressive myoclonus type 2, Lafora disease (laforin),
  • epilepsy, progressive myoclonus type 2A, Lafora disease (laforin),
  • LD,
  • EPM2,
  • laforin,
  • Lafora PTPase,
  • LAFPTPase,
  • lafora PTPase,
  • MELF,
  • EC 3.1.3.16,EC 3.1.3.48,
  • LDE,

Description…

epilepsy, progressive myoclonus type 2A, Lafora disease (laforin)

Attributes

QA State: Under Review
Type: Gene
Short Name:

Datasets

There are no datasets associated with this biomarker.

Organs

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

Studies

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

Publications

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

Resources

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

Announcement